FEXOFENADINE HYDROCHLORIDE
NDC 58602-427, FEXOFENADINE HYDROCHLORIDE ORAL, suspension, from Aurohealth LLC.
- Product NDC
- 58602-427
- Status
- Listed
- Labeler
- Aurohealth LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA213466
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58602-427 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FEXOFENADINE HYDROCHLORIDE30 mg/5mL
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58602-427-20 | 58602042720 | 1 BOTTLE in 1 CARTON (58602-427-20) / 240 mL in 1 BOTTLE |
| 58602-427-24 | 58602042724 | 1 BOTTLE in 1 CARTON (58602-427-24) / 120 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58602-427 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58602-427 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58602-427. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.